BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 15386362)

  • 1. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
    Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
    Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
    Bennett WP; Hollstein MC; Metcalf RA; Welsh JA; He A; Zhu SM; Kusters I; Resau JH; Trump BF; Lane DP
    Cancer Res; 1992 Nov; 52(21):6092-7. PubMed ID: 1394236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Mutation analysis of low-grade dysplasia and high-grade dysplasia/carcinoma in situ of the esophagus using laser capture microdissection.
    Kobayashi M; Kawachi H; Takizawa T; Uchida K; Sekine M; Kumagai J; Momma K; Nemoto T; Akashi T; Funata N; Eishi Y; Koike M
    Oncology; 2006; 71(3-4):237-45. PubMed ID: 17652955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
    Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
    Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis.
    Yasuda M; Kuwano H; Watanabe M; Toh Y; Ohno S; Sugimachi K
    Br J Cancer; 2000 Oct; 83(8):1033-8. PubMed ID: 10993651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
    Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
    Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
    Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
    Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
    Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal analysis of esophageal squamous cell carcinoma with intraepithelial components.
    Tamura H; Sugihara H; Bamba M; Tani T; Hosokawa M; Kodama M; Hattori T
    Pathobiology; 2001; 69(6):289-96. PubMed ID: 12324705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy.
    Rugge M; Bovo D; Busatto G; Parenti AR; Fawzy S; Guido M; Ancona E; Ninfo V; Ruol A; Shiao YH
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):171-6. PubMed ID: 9138659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India.
    Gaur D; Arora S; Mathur M; Nath N; Chattopadhaya TK; Ralhan R
    Clin Cancer Res; 1997 Nov; 3(11):2129-36. PubMed ID: 9815606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa.
    Ishii T; Murakami J; Notohara K; Cullings HM; Sasamoto H; Kambara T; Shirakawa Y; Naomoto Y; Ouchida M; Shimizu K; Tanaka N; Jass JR; Matsubara N
    Gut; 2007 Jan; 56(1):13-9. PubMed ID: 16785283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
    Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China.
    Wang LD; Zhou Q; Hong JY; Qiu SL; Yang CS
    Cancer; 1996 Apr; 77(7):1244-9. PubMed ID: 8608498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.